the aid library

LIST OPTIONS

Filter

5303

Sort by:

Direction:

Download (372)

View PDF (525)

Male Involvement in Maternal Health Care as a Determinant of Utilization of Skilled Birth Attendants in Kenya

Mageni, Judith Nekesa, Ann Mwagni, Samwel Mbugua, and Vincent Mukthar ICF International (2013) C1

DHS Working Papers No. 93

Download (365)

View PDF (517)

An Assessment of Contraceptive Use by Marriage Type among Sexually Active Men in Nigeria: Analysis of the 2013 Demographic and Health Survey.

Asa, S.S., A. Titilayo, and J. A. Kupoluyi. ICF International (2016) C2

DHS Working Papers No. 124

Download (194)

View PDF (268)

POLICY BRIEF - Accelerating Fertility Decline to Trigger the Demographic Dividend in Rwanda

National Institute of Statistics of Rwanda (NISR), the African Institute for Development Policy (AFIDEP) and UNFPA (2017) C2

The Demographic Dividend study on Rwanda assessed the socio-economic and human development potential of our country in the short, medium and long-term period using a comprehensive approach. It generated relevant policy and programme information to guide a well-informed polciy required to propel Rwan... more

Download (325)

View PDF (589)

IPCC Special Report on Climate Change and Land
recommended

The Intergovernmental Panel on Climate Change (2019) CC

An IPCC special report on climate change, desertification, land degradation, sustainable land management, food security, and greenhouse gas fluxes in terrestrial ecosystems As more frequent droughts and floods threaten the global food supply, humans are increasing their demands on water and land,... more

Download (270)

View PDF (501)

The human face of tuberculosis in Sudan

World Health Organization, Eastern Mediterranean; Stop TB Partnership (2010) C_WHO

Download (462)

View PDF (1109)

Indonesia: Disaster Management Reference Handbook

Center for Excellence in Disaster Management and Humanitarian Assistance (2018) C1

The Indonesian government has reformed its laws, policies, and institutions to better manage disaster risk since the significant 2004 Indian Ocean Tsunami. The Government of Indonesia now has contingency plans for every disaster-prone city which identifies its vulnerabilities, outlines the relief re... more

Download (529)

View PDF (418)

3MDG Sexual and Reproductive Health Indicator Guidelines

Three Millennium Development Goal Fund (3MDG) (2018) C1

Version-1, June 2018
This document provides 3MDG stakeholders with essential information on SRHR indicators, derived from the 3MDG Logical Framework, Data Dictionary for Health Service Indicators (2014 June, DoPH, MoHA), A Guide to Monitoring and Evaluating Adolescent Reproductive Health Progra... more

Download (201)

View PDF (254)

POLICY BRIEF - Unlocking Rwanda’s Potential to Reap the Demographic Dividend

National Institute of Statistics of Rwanda (NISR), the African Institute for Development Policy (AFIDEP) and UNFPA (2017) C2

Download (342)

View PDF (268)

Acting on the call

USAID (2018) C1

A Focus on the Journey to Self-Reliance for Preventing Child and Maternal Deaths . June 2018
The 2018 Acting on the Call report focuses on 25 countries’ journeys to self-reliance for preventing child and maternal deaths. Self-reliance is a country’s ability to finance and implement solution... more

Download (206)

View PDF (294)

The 2014 Myanmar Population and Housing Census: Thematic Report on Mortality

The Republic of the Union of Myanmar (2016) C1

Census Report Volume 4-B
In the 2014 Census, early-age mortality was measured from the responses to two simple retrospective questions on childbearing addressed to ever-married women aged 15 and over. These questions referred to how many live children they had ever given birth to, and how many ... more

Download (130)

View PDF (108)

Senegal: Malaria Operational Plan FY 2017

U.S. Presidents Malaria Initiative (2017) C2

This FY 2017 Malaria Operational Plan presents a detailed implementation plan for Senegal, based on the strategies of PMI and the National Malaria Control Program (NMCP) strategy. It was developed in consultation with the NMCP and with the participation of national and international partners involve... more

Download (80)

View PDF (150)

Burkina Faso: Malaria Operational Plan FY 2019

U.S. Global Malaria Coordinator (2019) C2

This FY 2019 Malaria Operational Plan presents a detailed implementation plan for Burkina Faso, based on the strategies of PMI and the National Malaria Control Program (NMCP). It was developed in consultation with the NMCP and with the participation of national and international partners involved in... more

Download (100)

View PDF (111)

Malaria Operational Plan FY 2018 Ethiopia

United States Agency for International Development United States Agency for International Development (2018) C1

This FY 2018 Malaria Operational Plan (MOP) presents a detailed implementation plan for Ethiopia, based on the strategies of PMI and the National Malaria Control Program (NMCP). It was developed in consultation with the Federal Ministry of Health (FMOH), NMCP, Ethiopian Public Health Institute (EP... more

Download (219)

View PDF (251)

Ending the hunger crisis: Response, recovery and resilience

IRC (2021) CC

A global hunger crisis -- fuelled by conflict, economic turbulence and climate-related shocks -- has been exacerbated by the COVID-19 pandemic. The number of people experiencing food insecurity and hunger has risen since the onset of the pandemic. The IRC estimates that the economic downturn alone w... more

Download (127)

View PDF (168)

Strategic plan towards ending TB in the WHO South-East Asia Region: 2021–2025

World Health Organization (WHO), Regional Office for South-East Asia (2021) C_WHO

The WHO End TB Strategy aims to end the global TB epidemic by 2030, in alignment with Goal 3 of the United Nations (UN) Sustainable Development Goals (SDGs). Member States of the World Health Organization (WHO) and the UN committed to ending the TB epidemic through adoption of WHO’s End TB Strateg... more

Download (145)

View PDF (209)

Global antimicrobial resistance and use surveillance system (‎GLASS)‎ report: 2022

World Health Organisation (WHO) (2022) C_WHO

The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance... more

Download (154)

View PDF (183)

Tracking urban health policies

World Health Organisation (WHO) (2023) C_WHO

To enhance health co-benefits across urban policies which tackle air pollution and climate change, WHO, in cooperation with various international, national, and local partners, implemented the Urban Health Initiative (UHI) pilot project in Accra, Ghana. The Initiative prompted the health sector to u... more

Download (100)

View PDF (110)

Global expenditure on health: Public spending on the rise?

World Health Organisation (WHO) (2021) C_WHO

The 2021 Report examines country health spending patterns and trends over the past 20 years, before the COVID-19 pandemic, with greater focus on public spending on health. The report also presents spending on primary health care, preliminary health expenditure in 2020 for a small set of countries (i... more

Download (245)

View PDF (329)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (21)

View PDF (10)

2021 Malawi Sustainability Index and Dashboard Summary

2021 Malawi Sustainability Index and Dashboard Summary (2021) CC2

The HIV/AIDS Sustainability Index Dashboard is a tool completed every two years by President’s Emergency Plan for AIDS Relief (PEPFAR) teams, host government and partner stakeholders to sharpen the understanding of each country’s sustainability landscape and to assist PEPFAR and other donors in ... more

IPCC Special Report on Climate Change and Land recommended

IPCC Special Report on Climate Change and Land
recommended